Records 1 - 2
| Correlation of genetic polymorphisms with clinical outcomes in pemetrexed-treated advanced lung adenocarcinoma patients.
Pharmacogenomics 2015 16 (4): 383-91.
Woo Hye In, Kim Jung A, Jung Hyun Ae, Kim Ka-Kyung, Lee Ji Yean, Sun Jong-Mu, Ahn Jin Seok, Park Keunchil, Lee Soo-Youn, Ahn Myung-
| Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression.
Molecular cancer 2010 9 (1): 188.
Zhang Xuchao, Zhang Shirley, Yang Xuening, Yang Jinji, Zhou Qing, Yin Lucy, An Shejuan, Lin Jiaying, Chen Shiliang, Xie Zhi, Zhu Mike, Zhang Xiaolin, Wu Yi-lo